7/23/2010

A Yale University study found the KRAS genetic mutation in 25% of ovarian cancer patients and in 61% of ovarian cancer patients with family histories of breast and ovarian cancers. The results suggest that the gene variant could serve as a genetic marker for the disease.

Full Story:
WebMD

Related Summaries